About Human Parathyroid Hormone 1 Receptor (PTH1R) Stable Cell Line

Parathyroid Hormone 1 Receptor (PTH1R) is a Class B G protein-coupled receptor (GPCR) that serves as the primary receptor for parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP). PTH1R is predominantly expressed in bone, kidney, cartilage, and other tissues involved in calcium and phosphate homeostasis. Upon activation by its ligands, PTH1R primarily couples to Gs proteins, stimulating adenylate cyclase activity and increasing intracellular cAMP levels, while also activating Gq-mediated phospholipase C signaling pathways. These signaling events regulate bone remodeling, mineral metabolism, skeletal development, and renal calcium reabsorption.

PTH1R plays a central role in maintaining calcium and phosphate balance within the body. In bone tissue, PTH1R signaling regulates the activity of osteoblasts and osteoclasts, influencing bone formation and resorption. In the kidney, activation of PTH1R promotes calcium reabsorption and phosphate excretion, helping maintain mineral homeostasis. Dysregulation of PTH1R signaling has been associated with osteoporosis, hyperparathyroidism, skeletal developmental disorders, and other metabolic bone diseases. Consequently, PTH1R has become an important therapeutic target for osteoporosis treatment, bone regeneration research, and endocrine drug discovery.

eEnzyme's Human PTH1R Stable Cell Line provides a reliable and reproducible cellular platform for investigating PTH1R-mediated signaling pathways and evaluating receptor-targeted therapeutics. The cell line enables quantitative assessment of PTH analogs, PTHrP peptides, agonists, antagonists, and novel modulators through cAMP assays, reporter gene assays, calcium mobilization assays, and other GPCR functional screening platforms. Researchers can utilize this stable cell line for receptor characterization, potency determination, lead optimization, biosimilar evaluation, and high-throughput screening applications supporting bone biology and metabolic disease research.

Applications of the PTH1R Stable Cell Line

• PTH1R receptor pharmacology studies
• Parathyroid hormone (PTH) signaling investigations
• PTHrP biology and receptor characterization
• Osteoporosis drug discovery and development
• Bone metabolism and skeletal biology research
• cAMP and calcium signaling assays
• Biosimilar potency and comparability testing
• High-throughput screening applications

Biological Significance of PTH1R

PTH1R is a master regulator of mineral metabolism and skeletal homeostasis. Activation of the receptor by PTH controls calcium and phosphate balance through coordinated effects on bone and kidney function. In bone tissue, intermittent PTH1R activation promotes anabolic bone formation, a mechanism that has been successfully exploited for osteoporosis therapies such as teriparatide and abaloparatide. In addition to its endocrine functions, PTH1R signaling plays essential roles in skeletal development, cartilage formation, and tissue remodeling through interactions with PTHrP. Because of its critical involvement in bone health, mineral metabolism, and endocrine regulation, PTH1R remains one of the most important GPCR targets in osteoporosis research, skeletal biology, regenerative medicine, and metabolic disease drug discovery. The PTH1R Stable Cell Line provides a valuable tool for studying receptor biology and advancing the development of next-generation therapeutics targeting bone and mineral disorders.